Last reviewed · How we verify

Gbt021601 — Competitive Intelligence Brief

Gbt021601 (gbt021601) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: unknown. Area: Rare Disease.

marketed unknown unknown Rare Disease Live · refreshed every 30 min

Target snapshot

Gbt021601 (gbt021601) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Gbt021601 TARGET gbt021601 Pfizer marketed unknown unknown
SINECATECHINS SINECATECHINS marketed Polyphenols Unknown 2006-01-01
PODOFILOX PODOFILOX marketed Topical antiviral Unknown 1990-01-01
POLIDEXIDE SULFATE POLIDEXIDE SULFATE marketed Unknown Unknown 1974-01-01
SUTILAINS SUTILAINS marketed Unknown Unknown 1969-01-01
Latanoprost plus adjunctive glaucoma medication Latanoprost plus adjunctive glaucoma medication Sight Sciences, Inc. marketed Prostaglandin analog with adjunctive glaucoma agent FP prostaglandin receptor (latanoprost component); adjunctive target unknown
Pf-07284892 pf-07284892 Pfizer marketed unknown unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (unknown class)

  1. Pfizer · 7 drugs in this class
  2. Pfizer Inc. · 3 drugs in this class
  3. Qilu Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gbt021601 — Competitive Intelligence Brief. https://druglandscape.com/ci/gbt021601. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: